Additionally, natural killer (NK) cells can enhance the specific responses of CD8+ T cells through cross‐presentation of tumor antigens, and the co‐infiltration of NK cells and CD8+ T cells in NSCLC is an independent predictor of favorable prognosis [10]. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.